Omega Laboratories, Life Diagnostics to open drugs-of-abuse testing lab in UAE

LabPulse.com staff writers
Feb 21, 2023
Scientists Pharmaceutical Laboratory Social

Mogadore, OH-based Omega Laboratories on Tuesday announced a partnership with Life Diagnostics to open a drugs-of-abuse testing laboratory in the United Arab Emirates (UAE).

The laboratory will provide drugs-of-abuse testing in the Middle East/North Africa (MENA) region and incorporate Omega's toxicology experience and information technology solutions, the firm said.

Established in 1998 at the heart of Abu Dhabi, Life Diagnostics provides a wide range of laboratory and radiology services under one roof and acquires the latest diagnostics technologies and instruments for clinical testing and imaging.

Financial and other terms of the partnership were not disclosed.

Latest in Collaboration
Pathology Digital Workstation Microscope Social
Paige, Leica Biosystems expand partnership to enhance digital pathology workflows
March 13, 2023
Lab Pathology Man Social
Pathology services provider PathGroup adopts Proscia digital platform
March 1, 2023
Bacteria Mycobacterium Tuberculosis Social
Roche, CDC expand partnership on HIV and TB support for healthcare systems in critical regions
February 28, 2023
Hands Shaking Deal Social
Quest Diagnostics, Tower Health ink multi-year testing agreement
February 16, 2023
Related Stories
Lab Cell Scientist
Research and Development
Sphere Fluidics opens new laboratory facilities to enable expansion, new product development
Digital Science Lab
CLIA
Nucleix announces CLIA certification, CAP accreditation for San Diego laboratory
Diagnostic Analyzer Lab Pcr
PCR
Standard BioTools debuts real-time PCR system for laboratory use
Hands Shaking Deal
Mergers & Acquisitions
Quest Diagnostics to acquire Summa Health’s outreach laboratory services business
More in Collaboration
Paige, Leica Biosystems expand partnership to enhance digital pathology workflows
Under the partnership, a co-branded version of Paige’s pathology platform will be introduced as the core interface between pathologists and Leica Biosystems hardware.
March 13, 2023
Pathology Digital Workstation Microscope Social
Pathology services provider PathGroup adopts Proscia digital platform
PathGroup supports more than 15,000 referring physicians and more than 200 hospital customers with diversified laboratory testing services and customer service.
March 1, 2023
Lab Pathology Man Social
Roche, CDC expand partnership on HIV and TB support for healthcare systems in critical regions
The public-private partnership, named Lab Networks for Health, aims to improve HIV and TB detection, prevention, and treatment in countries that have been hit hardest by the two diseases.
February 28, 2023
Bacteria Mycobacterium Tuberculosis Social
Quest Diagnostics, Tower Health ink multi-year testing agreement
Quest will support three hospitals within the Tower Health network: Reading Hospital; Phoenixville Hospital; and Pottstown Hospital in Pennsylvania.
February 16, 2023
Hands Shaking Deal Social
Cleveland Diagnostics, Quest Diagnostics expand access to blood-based prostate cancer test
When physicians order the IsoPSA prostate cancer test, their patients will provide blood specimens at a Quest patient service center. Quest will transport the blood samples for testing at a Cleveland Diagnostics’ laboratory.
February 13, 2023
Prostate Cancer Social
Siemens Healthineers, Unilabs ink 200-million euro agreement
In the first years of the agreement, Siemens Healthineers will install high- and mid-volume immunoassay and clinical chemistry analyzers, including the Atellica Solution and Atellica CI 1900, sample handlers, hemostasis analyzers, and automation solution
February 2, 2023
Scientists Pharmaceutical Laboratory Social
Most Popular
Quest launches long-COVID testing panels for consumers
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Patients prefer immediate test results, even when the news is bad
More in Collaboration
Genetic Technologies, Qiagen forming strategic alliance
Genetic Technologies said the alliance is expected to support the enhancement of its capabilities through software, hardware, consumable, and other technical solutions.
February 1, 2023
Sequencing Dna Rna Social
Beckman Coulter, MeMed collaborate to expand adoption of host immune response diagnostic test
MeMed developed its BV test to address the management of patients with acute infection in different clinical settings, including emergency departments, and distinguish between bacterial and viral infections early in the diagnostic process.
January 31, 2023
Sepsis Bacteria Social
Jana Care, Roche to develop blood-testing platform for chronic kidney and heart disease
The platform would enable patients to self-administer critical blood tests at home, and allow clinicians to review the test results remotely.
January 31, 2023
Cardiac Heart Eeg Social
VieCure, Labcorp collaborate on clinical workflows, genomic testing
The firms are aiming to assist patient-specific treatment plans by integrating Labcorp’s precision medicine testing with VieCure’s clinical decision-support tool.
January 25, 2023
Dna Sequencing Social
Jumpcode Genomics enters PacBio’s Compatible Partner program
Jumpcode’s Single Cell RNA Boost Kit is compatible with PacBio’s Multiplexed Arrays Sequencing (MAS-Seq) for 10x Single Cell 3’ kit, which allows researchers to remove uninformative fragments from single-cell RNA sequencing libraries prior to sequencing.
January 12, 2023
Sequencing Dna Rna Social
Qiagen, Helix collaborate to market companion diagnostic products for hereditary diseases
Under the agreement, Qiagen will be the exclusive marketing and contracting partner in the U.S. for Helix’s companion diagnostic services.
January 5, 2023
Dna Sequencing2
Page 1 of 35
Next Page